ES2190383B1 - Extracto de vitex agnus castus. - Google Patents

Extracto de vitex agnus castus.

Info

Publication number
ES2190383B1
ES2190383B1 ES200201072A ES200201072A ES2190383B1 ES 2190383 B1 ES2190383 B1 ES 2190383B1 ES 200201072 A ES200201072 A ES 200201072A ES 200201072 A ES200201072 A ES 200201072A ES 2190383 B1 ES2190383 B1 ES 2190383B1
Authority
ES
Spain
Prior art keywords
extract
vitex agnus
agnus castus
separation
dietary supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200201072A
Other languages
English (en)
Other versions
ES2190383A1 (es
Inventor
David Gregory Corley
Qing Lu
Ding Ming
John P. Troup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis Nutrition AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition AG filed Critical Novartis Nutrition AG
Publication of ES2190383A1 publication Critical patent/ES2190383A1/es
Application granted granted Critical
Publication of ES2190383B1 publication Critical patent/ES2190383B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Extracto de Vitex agnus castus obtenible mediante extracción de los frutos secos y pulverizados de la planta Vitex agnus castus con un disolvente de etanol al 90-100%, separación de la solución de extracción del resto del material vegetal, separación del disolvente de la solución de extracción y recuperación del extracto. También se proporciona un suplemento dietético que comprende un extracto de Vitex agnus castus que tiene un contenido en ácido linoléico de al menos 10% en peso y una fuente de calcio, así como el uso del extracto y del suplemento dietético para tratar estados que afectan particularmente a las mujeres.
ES200201072A 2001-05-09 2002-05-09 Extracto de vitex agnus castus. Expired - Fee Related ES2190383B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28984001P 2001-05-09 2001-05-09
US60/289840 2001-05-09

Publications (2)

Publication Number Publication Date
ES2190383A1 ES2190383A1 (es) 2003-07-16
ES2190383B1 true ES2190383B1 (es) 2004-10-16

Family

ID=23113333

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201072A Expired - Fee Related ES2190383B1 (es) 2001-05-09 2002-05-09 Extracto de vitex agnus castus.

Country Status (5)

Country Link
US (1) US20030054058A1 (es)
JP (1) JP2003012533A (es)
AU (1) AU772384B2 (es)
ES (1) ES2190383B1 (es)
GB (1) GB2377439B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20060105062A1 (en) * 2004-11-12 2006-05-18 Mccleary Edward L Composition and method for modulating addictive behaviors
US20050255192A1 (en) * 2004-05-13 2005-11-17 Prerna Chaudhry Yogurt products and method of preparation
FR2873934B1 (fr) * 2004-08-06 2007-12-14 Elysee Lab Procede d'extraction de glycolipides riches en omega 3 a partir de matieres vegetales alimentaires ainsi que poudre riche en omega 3 obtenue suite a la mise en oeuvre de ce procede
WO2007029263A1 (en) * 2005-09-05 2007-03-15 Ganga Raju Gokaraju Pharmaceutically active extracts of vitex leucoxylon, a process of extracting the same and a method of treating diabetes and inflammatory diseases therewith
FR2893848B1 (fr) * 2005-11-28 2011-11-11 Physcience Composition phytohormonale et son utilisation comme substitut hormonal
US20080160083A1 (en) * 2007-01-03 2008-07-03 Jarret Morrow Composition and method for treatment of premenstrual symptoms
JP5770504B2 (ja) * 2010-03-31 2015-08-26 株式会社ファンケル アディポネクチン産生促進剤
JP2012201593A (ja) * 2011-03-23 2012-10-22 Fancl Corp 糖尿病性脂肪肝の予防・改善・治療用組成物
FR2989557B1 (fr) * 2012-04-20 2016-01-08 Lisapharm Lab Nouvelles compositions alimentaires et leur mode de realisation
ES2675215T3 (es) * 2013-02-08 2018-07-09 General Mills, Inc. Productos alimentarios reducidos en sodio
CN113016970A (zh) * 2019-12-09 2021-06-25 南京宿根花卉植物园有限公司 一种含有园艺黄荆的植物固体饮料

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3442961C1 (de) * 1984-11-24 1985-08-14 Manfred Kriwet Haarpflegemittel
DE4305452A1 (de) * 1993-02-23 1994-08-25 Plantamed Arzneimittel Gmbh Verwendung von Extrakten der Pflanze Vitex Agnus castus zur Behandlung des Parkinson-Syndroms
DE19614848A1 (de) * 1995-05-12 1996-11-14 Zeller Max Soehne Ag Herstellung pflanzlicher Zubereitungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946679A (en) * 1988-07-25 1990-08-07 Thys Jacobs Susan Method for the treatment of premenstrual syndrome
US5354743A (en) * 1992-09-15 1994-10-11 Thys Jacobs Susan Method for the treatment of premenstrual syndrome with vitamin D
JP3676805B2 (ja) * 1992-09-15 2005-07-27 タイス−ジェイコブズ，スーザン 月経前症候群全症状のビタミンｄまたはビタミンｄおよびカルシウムによる治療方法
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US5942255A (en) * 1996-07-15 1999-08-24 The University Of Memphis Methods of enhancing lean tissue mass and bone mineral content and compositions therefor
AU1363299A (en) * 1997-10-23 1999-05-10 Pharmaprint, Inc. Pharmaceutical grade valerian, black cohosh, vitex agnus-castus, bilberry and milk thistle
US20020172732A1 (en) * 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3442961C1 (de) * 1984-11-24 1985-08-14 Manfred Kriwet Haarpflegemittel
DE4305452A1 (de) * 1993-02-23 1994-08-25 Plantamed Arzneimittel Gmbh Verwendung von Extrakten der Pflanze Vitex Agnus castus zur Behandlung des Parkinson-Syndroms
DE19614848A1 (de) * 1995-05-12 1996-11-14 Zeller Max Soehne Ag Herstellung pflanzlicher Zubereitungen

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LOCH, E.-G. et al. "Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus". Journal of Womens Health & Gender - Based Medicine", 2000, Vol. 9, nº 3, páginas 315-20. *
MEIER, B. et al. "Pharmacological activities of Vitex agnus-castus extracts in vitro". Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 2000, Vol. 7, nº 5, páginas 373-381. *
ODENTHAL, K.P. "Vitex agnus castus L., - traditional drug and actual indications". Phytotherapy Research, 1998, Vol. 12, Suppl. 1, páginas S160-161. *
SCHELLENGER, G.R. "Treatment for the premenstrual syndrome with agnus castus fruit extract: Prospective, randomized, placebo controlled study". BMJ, enero 2001, Vol. 322, Nº 7279, páginas 134-137. *

Also Published As

Publication number Publication date
GB0210437D0 (en) 2002-06-12
AU772384B2 (en) 2004-04-29
US20030054058A1 (en) 2003-03-20
ES2190383A1 (es) 2003-07-16
GB2377439B (en) 2005-04-06
AU3433802A (en) 2002-11-14
JP2003012533A (ja) 2003-01-15
GB2377439A (en) 2003-01-15

Similar Documents

Publication Publication Date Title
Makari et al. In vitro antioxidant activity of the hexane and methanolic extracts of Cordia wallichii and Celastrus paniculata
Kwak et al. In vitro antioxidant and anti-inflammatory effects of ethanol extracts from sprout of evening primrose (Oenothera laciniata) and gooseberry (Actinidia arguta)
CO2021001061A2 (es) Composición y método para tratar el dolor
Hammami et al. Impact of garlic feeding (A llium sativum) on male fertility
Enkhtaivan et al. Anti-influenza (H1N1) potential of leaf and stem bark extracts of selected medicinal plants of South India
ES8100673A1 (es) Procedimiento de preparacion de una fraccion rica en subs- tancias antioxidantes a partir de una materia vegetal que las contiene
AR067643A1 (es) Extractos ricos en proantocianidinas y procedimiento de preparcion relacionado
MX349768B (es) Proceso para producir articulos de origen de planta impregnados con una sustancia liquida de planta.
ES431347A1 (es) Procedimiento para extraer sustancias antioxidantes de una materia organica que las contiene.
Napagoda et al. Inhibition of 5-lipoxygenase as anti-inflammatory mode of action of Plectranthus zeylanicus Benth and chemical characterization of ingredients by a mass spectrometric approach
AR066822A1 (es) Extracto de planta y su uso terapeutico
ES2190383A1 (es) Extracto de vitex agnus castus.
Kill et al. Chemical characterization of synthetic cannabinoids by electrospray ionization FT-ICR mass spectrometry
Jaradat Quantitative estimations for the volatile Oil by using hydrodistillation and microwave accelerated distillation methods from Ruta graveolens L. and Ruta chalepensis L. leaves from Jerusalem area/Palestine
Raduan et al. Antioxidant capabilities of Litsea garciae bark extracts and their relation to the phytochemical compositions
JP2003012533A5 (es)
Mekala et al. Phytochemicals from the bark of Rhamnus caroliniana
Bessah et al. Essential oil composition of Erica arborea L. leaves from Algeria
Park et al. Antioxidative effects and component analysis of graviola (Annona muricata) leaf extract/fractions
Kumar et al. Evaluation of antioxidant activity of selected Indian medicinal plants
Ahn et al. Antioxidant Components of the Aerial Parts of Bidens frondosa L.
Threrapanithan et al. Anti-inflammatory and antioxidant activities of the Thai traditional remedy called “Leard-ngam” and its plant ingredients
Koba et al. Chemical composition and cytotoxic activity of essential oil of Chromolaena odorata L. growing in Togo
PE20211582A1 (es) Planta de stevia con bajo contenido de tiramina
Nasser et al. Isolation of coumarin from Mellilotus officinalis OF IRAQ

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030716

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2190383B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20101018